Making cell-free DNA testing accessible to all healthcare providers

ESMO CONGRESS 2026

Oct23

Coundown Timer

24

Days
:

12

Hours
:

16

Mins
:

26

Seconds

Date: 23 Oct

- 27 Sep 2026

ESMO CONGRESS 2026
Gene Solutions divider
Published: 21 September 2026

Details:

Multi-omic liquid biopsy will reshape clinical practice only when it moves from technological innovation to evidence-based decisions that health systems can implement at scale. 

This is the focus of the ESMO 2026 Industry Satellite Symposium hosted by Gene Solutions: 

AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation 

 

Co-chairs: 

Prof. Herbert Ho Fung Loong, The Chinese University of Hong Kong, Hong Kong SAR 

Prof. Umberto Malapelle, University Federico II of Naples, Italy 

The session will address the clinical challenges of current multi-cancer early detection tests; the validation of AI-enabled multi-omic cfDNA approaches and pathways to implementation in diverse settings; Asian real-world evidence on ctDNA MRD monitoring and profiling at scale, with an emphasis on affordability and high-precision applications; multi-omic signals for next-generation precision oncology and immunogenetic discovery; and complementary translational models, including 3D patient-derived organoids. The session will conclude with a panel discussion on bridging regional evidence to global practice. 

📅 Friday, 23 October 2026
🕘 09:45–11:15 CEST 

📍 Salamanca Auditorium, Hall 10, IFEMA Madrid 

Faculty also includes Dr. Le Son Tran and Dr. Vien Le (Medical Genetics Institute, Viet Nam), Prof. Aya El-Helali (The University of Hong Kong), and Asst. Prof. Lucksamon Thamlikitkul (Siriraj Hospital, Mahidol University, Thailand). 

🔗 ESMO session link: https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal/show/session/106 

🔗 Read more about the symposium: https://genesolutions.com/news/esmo-congress-2026-gene-solutions-to-present-ai-enabled-multi-omic-liquid-biopsy

The symposium reflects Gene Solutions’ mission to make precision cell-free DNA testing accessible to millions of people across the cancer care continuum, so more people can receive an answer in time to act. 

Stay tuned for further symposium updates from Gene Solutions.

This non-promotional medical educational symposium is organized and funded by Gene Solutions for healthcare professionals only.